Research Antibodies & Reagents Market by Product (Antibodies, Reagent), Technology (Enzyme-linked Immunosorbent Assay, Flow Cytometry, Immunofluorescence), Indication, Application, End User - Global Forecast 2024-2030

Research Antibodies & Reagents Market by Product (Antibodies, Reagent), Technology (Enzyme-linked Immunosorbent Assay, Flow Cytometry, Immunofluorescence), Indication, Application, End User - Global Forecast 2024-2030


The Research Antibodies & Reagents Market size was estimated at USD 16.54 billion in 2023 and expected to reach USD 18.55 billion in 2024, at a CAGR 12.02% to reach USD 36.62 billion by 2030.

Research antibodies are proteins produced by the body's immune system to respond to harmful substances or antigens, such as bacteria and viruses. Scientists synthetically produce these antibodies in laboratories for research purposes. Laboratory-produced research antibodies bind to specific antigens, thus marking them for identification, detection, or neutralization. These antibodies are integral in many research operations, including enzyme-linked immunosorbent assay (ELISA), immunohistochemistry, flow cytometry, western blotting, and immunofluorescence. Reagents in the context of scientific research refer to any substance that is utilized to induce a chemical reaction or to experiment if a reaction occurs. The wide array of research reagents entails enzymes, solvents, catalysts, buffers, and more, each with distinct uses and applications. Reagents play critical roles in molecular biology research, facilitating processes such as DNA replication, RNA transcription, protein synthesis, and cell lysis. The research antibodies and reagents market refers to the products, tools, and services researchers use in various fields such as healthcare, biotechnology, pharmaceuticals, and academic institutions to study diverse biological processes. Several factors contribute to the growth of the research antibodies and reagents market, including increasing research activities by pharmaceutical and biopharmaceutical companies and the rising popularity of proteomics and genomics research. The emerging trend of research antibodies & reagents in personalized medicine and protein therapeutics supports this upward market growth. However, the growth of the research antibodies and reagents market is facing certain challenges, including the high cost of antibody development processes, and quality concerns, and a lack of reproducible results of research antibodies & reagents. On the other hand, increasing R&D in research antibodies & reagents and rising focus on discovering novel biomarkers present potential opportunities for the market to grow in the coming years.

Please Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing research activities by pharmaceutical and biopharmaceutical companies
5.1.1.2. Rising popularity of proteomics and genomics research
5.1.1.3. Emerging trend of research antibodies & reagents in personalized medicine and protein therapeutics
5.1.2. Restraints
5.1.2.1. High cost of antibody development processes
5.1.3. Opportunities
5.1.3.1. Increasing R&D in research antibodies & reagents
5.1.3.2. Rising focus on discovering novel biomarkers
5.1.4. Challenges
5.1.4.1. Quality concerns and a lack of reproducible results of research antibodies & reagents
5.2. Market Segmentation Analysis
5.2.1. Product: Increasing popularity of antibodies for detection and quantification of target proteins
5.2.2. Technology: Increasing usage of research antibodies & reagents in flow cytometry for immunophenotyping
5.2.3. Indication: Expanding application of research antibodies & reagents for identification of pathogens in infectious diseases
5.2.4. Application: Rising utilization of research antibodies and reagents for drug development tailored to specific therapeutic targets
5.2.5. End-user: Expanding usage of research antibodies & reagents across pharmaceutical & biotechnology companies
5.3. Market Trend Analysis
5.3.1. Increasing government investment for drug discovery coupled with robust foothold of major companies in Americas region
5.3.2. Improving healthcare infrastructure and rising investment in life sciences research in the Asia-Pacific region
5.3.3. Expanding government support for research and development in the field of genomics and strong foothold of major biotechnology companies in the EMEA region
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis
6. Research Antibodies & Reagents Market, by Product
6.1. Introduction
6.2. Antibodies
6.3. Reagent
7. Research Antibodies & Reagents Market, by Technology
7.1. Introduction
7.2. Enzyme-linked Immunosorbent Assay
7.3. Flow Cytometry
7.4. Immunofluorescence
7.5. Immunohistochemistry
7.6. Immunoprecipitation
7.7. Western Blotting
8. Research Antibodies & Reagents Market, by Indication
8.1. Introduction
8.2. Immunology
8.3. Infectious Diseases
8.4. Neurobiology
8.5. Oncology
8.6. Stem Cells
9. Research Antibodies & Reagents Market, by Application
9.1. Introduction
9.2. Drug Development
9.3. Genomics
9.4. Proteomics
10. Research Antibodies & Reagents Market, by End User
10.1. Introduction
10.2. Academic & Research Institutions
10.3. Contract Research Organizations
10.4. Pharmaceutical & Biotechnology
11. Americas Research Antibodies & Reagents Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Research Antibodies & Reagents Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Research Antibodies & Reagents Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. GenScript Expands Range of Reagent Services, Adding Circular RNA and Lipid Nanoparticles Formulation
14.3.2. Bio-Rad Laboratories, Inc. Extends Range of Antibody Markers Conjugated to StarBright Dyes
14.3.3. Danaher to Acquire Abcam plc
14.3.4. ERS Genomics & Santa Cruz Biotechnology Enter Into CRISPR/Cas9 Licensing Agreement
14.3.5. Teknova Announces Opening of New GMP-Certified Facility, Increasing Manufacturing Capacity for Custom, High-Quality Life Sciences Reagents
14.3.6. Lonza Group Ltd. to Acquire Synaffix and Strengthen Antibody-Drug Conjugates Offering
14.3.7. BD and A*STAR Collaborate to Advance Ultra-High Dimensional Analysis in Flow Cytometry for Immunology Research
14.3.8. Teknova and Sartorius Look to Address Critical Pain Points in AAV Bioprocessing
14.3.9. Bio-Techne And Cell Signaling Technology Announce Partnership To Validate Simple Western Antibodies
14.3.10. Cytek Biosciences, Inc. Partners with Bio-Rad Laboratories, Inc. to Expand Reagent Portfolios
15. Competitive Portfolio
15.1. Key Company Profiles
15.2. Key Product Portfolio
FIGURE 1. RESEARCH ANTIBODIES & REAGENTS MARKET RESEARCH PROCESS
FIGURE 2. RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. RESEARCH ANTIBODIES & REAGENTS MARKET DYNAMICS
FIGURE 7. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 14. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 16. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. RESEARCH ANTIBODIES & REAGENTS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 26. RESEARCH ANTIBODIES & REAGENTS MARKET, FPNV POSITIONING MATRIX, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings